Melfalan Varifarma
THERAPEUTIC AREA: Oncology / Hematology + Oncology + Transplant
ACTIVE PRINCIPLE: Melphalan
PRESENTATION: 2 mg x 25 coated tablets
INDICATION:
- Ovarian Cancer
- Multiple Myeloma
COUNTRIES WHERE IT IS MARKETED:
